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Expression of p16
Ink4a and p19 Arf increases with age in both rodent and human tissues. However, whether these tumour suppressors are effectors of ageing remains unclear, mainly because knockout mice lacking p16 Ink4a or p19 Arf die early of tumours. Here, we show that skeletal muscle and fat, two tissues that develop early ageing-associated phenotypes in response to BubR1 insufficiency, have high levels of p16
Ink4a and p19 Arf . Inactivation of p16 Ink4a in BubR1-insufficient mice attenuates both cellular senescence and premature ageing in these tissues. Conversely, p19
Arf inactivation exacerbates senescence and ageing in BubR1 mutant mice. Thus, we identify BubR1 insufficiency as a trigger for activation of the Cdkn2a locus in certain mouse tissues, and demonstrate that p16
Ink4a is an effector and p19 Arf an attenuator of senescence and ageing in these tissues.
Cellular senescence is a state of irreversible growth arrest that can be induced by various cellular stressors 1, 2 . The Cdkn2a locus encodes two separate tumour suppressors, p16
Ink4a (A001711), a cyclin-dependent kinase (Cdk) inhibitor that can block G 1 -S progression when present above a certain level, and p19
Arf (A001713), a positive regulator of the transcription factor p53 that integrates and responds to a wide variety of cellular stresses 1, [3] [4] [5] . Both p16 Ink4a and p19 Arf are effectors of senescence in cultured cells 6 and their levels increase with ageing in many tissues 7, 8 . This has led to speculation that their induction is causally implicated in in vivo senescence and organismal ageing. However, rigorous testing of this notion has been difficult because mice that lack p16 Ink4a or p19 Arf die of cancer long before they reach the age at which normal mice start to develop age-related disorders 1, 2 . Recent evidence in middle-aged p16
Ink4a knockout mice indicates that the age-induced expression of p16 Ink4a limits the proliferative and regenerative capacity of progenitor populations [9] [10] [11] . Yet, whether the increased stem-cell proliferation and tissue regeneration seen in p16
Ink4a knockouts actually delay onset of age-related pathologies remains unknown because of the limited animal lifespan 1, 12 . One approach to study the role of p16 Ink4a and p19 Arf in ageing would be to determine whether their respective inactivation by single gene mutations, in mouse models that develop ageing-associated pathologies at an early age, would prevent or delay premature ageing. Mutant mice with low levels of the mitotic checkpoint protein BubR1 (called BubR1 hypomorphic or BubR1
H/H mice, A003172) undergo premature separation of sister chromosomes and develop progressive aneuploidy along with various progeroid phenotypes that include short lifespan, cachectic dwarfism, lordokyphosis (abnormal curvature of the spine), sarcopaenia (age-related skeletal muscle atrophy), cataracts, craniofacial dysmorphisms, arterial stiffening, loss of (subcutaneous) fat, reduced stress tolerance and impaired wound healing [13] [14] [15] . During the course of natural ageing, several mouse tissues show a marked decline in BubR1 protein expression, which, combined with the observation that BubR1
H/H mice age prematurely, suggests a possible role for BubR1 in regulating natural ageing [13] [14] [15] . Here we show that certain mouse tissues induce p16
Ink4a and p19
Arf in response to BubR1 hypomorphism. Using BubR1 H/H mice in which these tumour suppressors are lacking, we have demonstrated that p16
Ink4a is an effector of cellular senescence and ageing, whereas, p19
Arf acts to suppress cellular senescence and ageing.
RESULTS
p16
Ink4a inactivation increases the lifespan of BubR1 H/H mice To determine the requirement for p16
Ink4a in the development of progeroid phenotypes in BubR1-insufficient mice, we bred BubR1 Ink4a-/-mice were generated and monitored for development of age-related phenotypes for a period of one year. Inactivation of p16
Ink4a extended the lifespan of BubR1 H/H mice by 25% (Fig. 1a) . Although the median lifespan of BubR1 H/H mice was extended in the absence of p16 Ink4a , the maximum lifespan was not, suggesting that the condition(s) that cause(s) death was not rescued by p16
Ink4a inactivation.
A R T I C L E S p16
Ink4a loss blunts sarcopaenia induced by BubR1 insufficiency A prominent ageing-associated phenotype of BubR1 H/H mice is the development of lordokyphosis 13 . 
than in BubR1
H/H mice (Fig. 1b) . Lordokyphosis is associated with both osteoporosis and age-related degenerative loss of muscle mass and strength (sarcopaenia) in wild-type mice of extremely advanced age 16 . Histological evaluation of longitudinal femur sections from kyphotic BubR1 H/H mice revealed no evidence for osteoporosis ( Supplementary  Information, Fig. S1a, b) . Histopathology on gastrocnemius and paraspinal muscles of 5-month-old BubR1 H/H mice, however, revealed clear signs of skeletal muscle atrophy and degeneration ( Fig. 1d and data not shown). Muscle degeneration was greatly reduced in BubR1 H/H muscles lacking p16 Ink4a (Fig. 1d, e) . In addition, abdominal muscles of BubR1
H/H mice were poorly developed, as revealed by macroscopic analysis and magnetic resonance imaging ( Fig. 1f ; Supplementary  Information, Fig. S1c ). Depletion of p16
Ink4a resulted in substantial correction of this defect. These data demonstrate that p16 Ink4a has a major role in establishing sarcopaenia in BubR1
H/H mice. p16
Ink4a limits the regenerative capacity of β cells and has been linked to pancreatic islet atrophy and development of diabetes 9, 17, 18 , which in turn can cause muscle atrophy through accelerated degradation of muscle protein 19 . This prompted us to test whether the sarcopaenia observed in BubR1
H/H mice might be due to β cell failure. BubR1
H/H mice showed highly efficient glucose clearance in a glucose-tolerance test ( Supplementary Information, Fig. S2a ). Complementary blood insulin measurements indicated that insulin sensitivity was not impaired in BubR1 H/H mice and showed no evidence for insulin resistance ( Supplementary Information, Fig. S2b ). Furthermore, overall pancreatic morphology, as well as islet size, shape and abundance were similar -mediated β cell degeneration or insulin resistance.
BubR1 and p16
Ink4a levels are inversely linked in skeletal muscle To determine whether BubR1 may have a role in normal skeletal muscle ageing, we measured BubR1 protein levels in skeletal muscle of young and old wild-type mice by western blot analysis. Gastrocnemius muscles had considerably higher levels of BubR1 protein at 2 months than at 35 months of age ( Fig. 2a; Supplementary Information, Fig. S6a ). BubR1 transcripts were undetectable by qRT-PCR in the gastrocnemius of 35-month-old mice but were readily present at 2 months (data not shown), suggesting that reduced BubR1 transcriptional activity contributes to the decline in BubR1 protein levels at advanced age. In contrast to BubR1 transcription, p16
Ink4a transcription increased markedly with age in gastrocnemius muscles of old wild-type mice (Fig. 2b) . Gastrocnemius of 2-and 5-month-old BubR1 H/H mice also had high p16 Ink4a transcript levels (Fig. 2b) Supplementary Information, Fig. S2d ). Transcript levels of p16
Ink4a
were similarly elevated for 3-week-old, and 2-and 5-month-old mice (Fig. 2b) , indicating that p16
Ink4a induction is an early response to BubR1 hypomorphism that precedes histological signs of sarcopaenia.
Increased expression of p16 Ink4a with age in adult stem cells is associated with reduced tissue repair and regeneration in several mouse tissues [9] [10] [11] [12] .
To explore whether p16
-mediated exhaustion of myogenic stem-cell potential might contribute to premature sarcopaenia in BubR1
H/H mice, in vitro myoblast-to-myofibre differentiation assays were performed on gastrocnemius muscles from 5-month-old wild-type, BubR1 H/H and BubR1
Ink4a-/-mice. In these assays, the average number of myotubes obtained per milligram of muscle tissue was about 7-fold lower in 
;p16
Ink4a-/-mice as detected by the use of slit light after dilation of eyes. The curves are significantly different (P < 0.0001, log-rank test). We note that no wild-type or p16
Ink4a-/-mice developed cataracts during this observation period. 
BubR1
H/H mice than in wild-type mice (Fig. 2c) . By contrast, only a 2-fold reduction in myotube formation was observed in BubR1
H/H mice lacking p16
Ink4a
. To confirm these data, 5-month-old wild-type, BubR1 H/H and BubR1
Ink4a-/-mice were challenged to regenerate muscle fibres by injection of cardiotoxin, a 60-amino-acid polypeptide that causes acute injury by rapidly destroying muscle fibres 20 . Consistent with our in vitro data, muscle regeneration was overtly delayed in BubR1 H/H mice, but not in BubR1
Ink4a-/-counterparts ( Fig. 2d) . Collectively, these data indicate that p16 Ink4a promotes sarcopaenia in BubR1 H/H mice, at least in part, by impairing muscle regeneration.
p16
Ink4a loss attenuates ageing in selective BubR1 hypomorphic tissues Loss of p16
Ink4a caused a modest, yet significant, delay in the latency of cataract formation in BubR1 H/H mice (Fig. 3a) . Aged skin is characterized by reduced dermal thickness and subcutaneous adipose tissue, both of which are observed in BubR1 H/H mice at young ages 13 . At 2 months of age, BubR1
Ink4a-/-and p16 Ink4a-/-mice had similar amounts of subdermal adipose tissue (Fig. 3b ). As expected, the mean thickness of the subcutaneous adipose layer decreased notably in 5-month-old BubR1 H/H mice. This decline was not accompanied by increased fat storage in liver tissue ( Supplementary Information, Fig. S2e ). The decrease in subcutaneous fat was much less severe in age-matched BubR1
Ink4a-/-mice ( Fig. 3b) delay of premature ageing, such as eye and (subdermal) adipose tissue, showed strong induction of p16 Ink4a expression in response to BubR1 hypomorphism ( Fig. 3c, d ; Supplementary Information, Fig. S6b, c) .
BubR1
H/H tissues in which p16 Ink4a inactivation has no discernible corrective effect, such as dermis, brain, aorta, testis and ovary, did not exhibit significant p16 Ink4a induction (Fig. 3c and data not shown). Furthermore, mutant tissues that are not subjected to premature ageing, including lung, pancreas, colon and liver 13 , maintained low p16 Ink4a expression levels. Together, these data demonstrate that p16 Ink4a is activated in a subset of tissues in BubR1
H/H mice, where it contributes to progeroid phenotypes.
p16
Ink4a loss attenuates in vivo senescence BubR1 is a putative E2F-regulated gene 21 and loss of p16 Ink4a leads to increased E2F transcriptional activity 22 . Accordingly, attenuation of ageing in skeletal muscle, fat and eye may be the result of increased BubR1 gene expression. However, this is unlikely as BubR1 transcript levels in these tissues were not affected by loss of p16 Ink4a (Fig. 4a) . As p16 Ink4a is an effector of cellular senescence, p16
Ink4a deletion may delay ageing in hypomorphic mice by decreasing senescence. As shown in Fig. 4b, BubR1 H/H adipose tissue expresses high levels of senescence-associated (SA)-β-galactosidase, a marker of cellular senescence 23 . SA-β-galactosidase staining was much lower in adipose tissue of BubR1
Ink4a-/-mice (Fig. 4b) . Skeletal muscles of 2-month-old BubR1
H/H mice did not stain positive for SA-β-galactosidase but expressed high levels of several other senescence-associated genes, including Igfbp2, Nrg1, Mmp13 and PAI-1 [24] [25] [26] [27] (Fig. 4c) . Expression of these markers was decreased markedly in skeletal muscles of age-matched BubR1
Ink4a-/-mice. A key feature of senescence is loss of proliferative potential. In vivo 5-bromo-2-deoxyuridine (BrdU) labelling showed that 2-month-old BubR1 H/H mice had much lower percentages of cycling cells in skeletal muscle and fat than wild-type mice (Fig. 4d) . These reductions were less profound in Arf and p15 Ink4b antibodies. Anti-tubulin antibody was used as a loading control. Uncropped images of the scans are shown in Supplementary  Information, Fig. S6b, 
BubR1
H/H ;p16
Ink4a-/-mice. Collectively, these data suggest that BubR1 hypomorphism causes cellular senescence in adipose tissue and skeletal muscle through a p16 Ink4a -dependent mechanism. As p16
Ink4a inactivation attenuates both senescence and ageing in these tissues, the mechanism by which BubR1 hypomorphism accelerates the ageing phenotypes may involve p16
Ink4a -induced senescence. Besides p16 Ink4a , p19 Arf is expressed at increased levels in many tissues of wild-type mice with advanced age 7 , including skeletal muscle (Fig. 5a ). Although p19
Arf is an established effector of senescence in cultured mouse embryonic fibroblasts (MEFs), its role in senescence and ageing in the context of the whole organism has not been clarified 1, 2 . To explore the role of p19 Arf in BubR1-mediated ageing, we analysed its relative expression in tissues from 2-monthold BubR1
H/H and BubR1 +/+ mice. Increased p19 Arf expression was consistently observed in BubR1
H/H tissues that were subjected to premature ageing and had high p16
Ink4a levels, including skeletal muscle, (subdermal) adipose tissue and eye, but not in tissues that developed age-related pathology in a p16
Ink4a -independent fashion or had no age-related phenotypes (Fig. 5b, c Supplementary  Information, Fig. S3b ).
p19
Arf disruption accelerates ageing in BubR1 H/H mice To determine whether p19
Arf also acts as an effector of ageing in BubR1 H/H mice, 41 BubR1 H/H ;p19 Arf-/-mice were generated and monitored for development of age-related phenotypes. Surprisingly, lordokyphosis developed at a significantly faster rate in BubR1
Arf-/-mice than in BubR1 H/H mice (Fig. 6a, b) . Six-week-old BubR1 H/H ;p19
Arf-/-mice had significantly smaller fibres in gastrocnemius and abdominal muscles than age-matched BubR1 H/H mice ( Fig. 6c ; Supplementary  Information, Fig. S4a ), indicating that muscle wasting was accelerated in the absence of p19 Arf . Cataract formation was also significantly accelerated when p19
Arf was absent (Fig. 6d) . Skinned 6-week-old BubR1
Arf-/-mice showed overt reductions in deposition of adipose tissue (Fig. 6b) . This was confirmed by weighing inguinal adipose tissue (IAT, Fig. 6e) Ink4a -independent ageing or lacking age-related pathologies (Fig. 6g) , arguing against this possibility.
Inactivation of p19
Arf increases cellular senescence Next, we investigated whether p19
Arf loss accelerates ageing in BubR1
H/H mice through increased senescence. Indeed adipose tissue of 6-week-old BubR1
Arf-/-mice showed much higher SA-β-galactosidase activity than that of corresponding BubR1 H/H mice (Fig. 7a) . Furthermore, two senescence-associated genes, Igfbp2 and Nrg1, which are expressed at increased levels in gastrocnemius muscles of 6-week-old BubR1 H/H mice, were further elevated in corresponding muscles of age-matched BubR1 H/H ;p19 Arf-/-mice (Fig. 7b) . In vivo BrdU incorporation showed that cell proliferation in skeletal muscle and fat was considerably lower in BubR1
Arf-/-mice than in BubR1 H/H mice (Fig. 7c) . Collectively, these data indicate that p19
Arf induction in BubR1 H/H mice functions to prevent or delay senescence and provide further evidence for the notion that in vivo senescence promotes ageing. Arf caused a marked decrease in senescence in BubR1
H/H MEFs, whereas inactivation of p16 Ink4a had no effect ( Supplementary Information, Fig. S5a, b) Ink4a-/-mice (Fig. 8b) . Sarcomas, the most prevalent tumour type in p16
Ink4a-/-mice, were rare in BubR1
Ink4a-/-mice and not present in BubR1 H/H mice. Thus, the effect of BubR1 insufficiency is synergistic with that of p16
Ink4a loss during tumorigenesis in lung epithelial cells, but not in other cell types (see Supplementary Discussion). BubR1
Arf-/-and p19 Arf-/-mice, however, had overlapping tumour-free survival curves (Fig. 8c) , indicating that BubR1 insufficiency and p19
Arf loss do not synergize in tumorigenesis.
DISCUSSION
Here, we report that inactivation of p16 Ink4a attenuates the development of age-related pathologies in BubR1
H/H tissues with elevated p16 Ink4a . This shows that induction of p16
Ink4a by cellular stress resulting from BubR1-insufficiency drives the development of ageing-associated phenotypes, and provides direct evidence for a causal involvement of this tumour suppressor in organismal ageing. Importantly, skeletal muscle and fat, two tissues that are subject to p16 Ink4a -dependent ageing when BubR1 levels are low, have higher numbers of replicating cells and show decreased expression of senescence-associated proteins in the absence of p16
Ink4a
. These observations support the notion that p16
Ink4a contributes to ageing-associated pathologies through accumulation of senescent cells. This is a significant finding as evidence that cellular senescence promotes ageing has thus far been largely circumstantial 2, 6 .
BubR1
H/H mouse tissues, in which p16 Ink4a is elevated, also have increased p19
Arf . However, p19 Arf inactivation accelerates rather than delays ageing in these tissues, indicating that this tumour suppressor provides anti-ageing activity. This seems surprising, considering that p19
Arf is an effector of senescence in cultured cells 2, 6 . However, the recent observation that transgenic mice carrying an extra copy of both p19
Arf and p53 are protected from ageing-associated damage and live longer than normal mice 28 , is consistent with our finding that p19
Arf has anti-ageing activity in BubR1 H/H mice. It has been proposed that the p19 Arf -p53 pathway in response to low, chronic stress, may primarily induce genes that promote cell survival and repair, thereby extending lifespan 5, 28, 29 . High, acute types of stress, on the other hand, may accelerate ageing by triggering a more robust p53 response, causing irreversible cell-cycle arrest and/or apoptosis 5, [29] [30] [31] . Therefore, one possibility is that p19
Arf may elicit a p53 transcriptional response that provides protection against cellular stress resulting from BubR1 hypomorphism, thus delaying the onset of cellular senescence. The observation that skeletal muscle and fat from BubR1 H/H mice lacking p19 Arf accumulate more senescent cells is consistent with this idea. Strong additional support for the conclusion that p19
Arf has anti-ageing activity is provided by our unpublished observations indicating that BubR1 . The molecular basis of this similarity is unclear, although, based on the known roles of each protein, it is unlikely that BubR1 and BmalI are functionally connected. However, it is possible that downstream pathways that respond to stress resulting from Bmal1 loss and BubR1 hypomorphism are shared.
METHODS
Generation of compound mutant mice. BubR1
H/H mice were generated as described previously 13 . p16
Ink4a and p19 Arf knockout mice have been generated previously and were acquired from the Mouse Models of Human Cancers Consortium located at the National Cancer Institute, Frederick 33, 34 . All mice were on a mixed 129 × C57BL/6 genetic background. They were housed in a pathogenfree barrier environment for the duration of the study. Experimental procedures involving the use of these laboratory mice were reviewed and approved by the Institutional Animal Care and Use Committee of the Mayo Clinic. Prism software (GraphPad Software) was used for generation of all survival curves and for statistical analyses.
Collection and analysis of tumours. Moribund mice were killed and all major organs were screened for overt tumours using a dissection microscope. Tumours that were collected were processed by standard procedures for histopathology. A Fisher's exact test was used to compare tumour incidence proportions across the genotypes for mice that developed tumours. Board-certified pathologists assisted in the histological evaluation of tumour sections.
Analysis of progeroid phenotypes. Bi-weekly, mice were screened for the development of overt cataracts by examining dilated eyes with a slit-light. Incidence of lordokyphosis was checked bi-weekly. Mice that showed lordokyphosis for three consecutive monitoring periods were determined to have this condition. Various skeletal muscles were collected and processed for histology as described previously 35, 36 . Fibre diameter measurements were performed on cross sections of gastrocnemius and abdominal muscles from 6-week-old male mice (n = 3 mice per genotype). A total of 50 fibres were measured per muscle using a calibrated computer program (Olympus MicroSuite Five). Dissection, histology and measurements of dermal and adipose layers of dorsal skin were performed as described previously 16 . Values represent an average of four males. Analysis of arterial wall stiffening was performed as described previously 14 . Measurements of body weight and IAT were performed on 6-week-old males (n = 3 per genotype). Oral glucose tolerance tests were performed on 5-month-old male mice (n = 5 per genotype) as described by the Jackson Laboratory (www.jax.org). Insulin measurements were performed as described previously 37 .
Quantitative real-time PCR. Total RNA was extracted from tissues using a Qiagen RNeasy RNA isolation kit according to the manufacturer's protocol. Transcription into cDNA was performed using random hexamers and SuperScript III reverse transcriptase (Invitrogen) according to the manufacturer's instructions. All PCR reactions used SYBR green PCR Master Mix (Applied Biosystems) to a final volume of 12 µl, with each cDNA sample performed in triplicate in the ABI PRISM 7900 Sequence Detection System (Applied Biosystems) according to the protocol of the manufacturer. All experiments were performed on organs/tissues from at least three different animals in each age group and genotype. Analysis of satellite-cell function. Analysis of in vivo satellite-cell function were carried out as described previously 20 . Briefly, mice anaesthetized with avertin (200 mg kg -1 , i.p.) were given a single 50-µl injection of cardiotoxin (10 µM; Calbiochem) into the gastrocnemius muscle. After this injection, the skin incision was closed with a nylon suture. Mice were allowed to recover and then were analysed at both 5 and 18 days post-injection by routine histology. Isolation and culture of skeletal muscle satellite cells were performed as described previously 45 . Briefly, hindlimb muscles of 5-month-old mice were removed and trimmed of excess connective tissue and fat. Minced muscles were subjected to several 15-min rounds of digestion at 37 °C in incubation medium (50% DMEM high glucose (GIBCO)/50% F-12K (CellGro)/168 U ml -1 collagenase type II (Worthington)/0.04% Trypsin (GIBCO)). Once fully digested, cells were successively filtered through 70-and 40-µm strainers, collected by centrifugation at 300g for 5 min and resuspended in propagation medium (DMEM high glucose/15% FCS (GIBCO)/glutamine (CellGro)/penicillin-streptomycin (CellGro)). After seven days in culture, differentiation medium (propagation medium with 2% FCS) was applied and cells were fixed seven days after transfer to the medium. Myotube formation was quantified using the total number of myotubes for each sample normalized to the muscle mass extracted.
Magnetic resonance imaging.
Magnetic resonance images with a 7-tesla scanner (Bruker) were obtained in 2%-isofluorane anaesthetized mice using a spinecho method as described previously 46 . Digital images were analysed with the Metamorph software (Visitron, Universal Imaging). The ratio of muscle area (paraspinal and chest or abdominal wall muscles) to total body cross-section was measured at the distal thorax and mid-abdomen levels.
In vivo BrdU incorporation. At 24 and 6 h before tissue collection, male mice of various genotypes were injected intraperitoneally with 200 µl of BrdU (10 mg ml -1 ; Sigma) in PBS. Mice were anaesthetized (avertin, 200 mg kg -1 , i.p.) and successively perfused (transcardially) with PBS and 10% formalin. Organs were collected and embedded in paraffin. Five-µm sections were prepared and stained for BrdU according to the manufacturer's protocol (BD Pharmingen). The percentage of BrdU-positive cells was determined by counting total and BrdU-positive nuclei in 10 non-overlapping fields at ×40 magnification (n =3 mice per genotype).
Generation and culture of MEFs. MEFs were generated as described previously 47 . BrdU incorporation assays on MEFs were performed according to the manufacturer's protocol (BD Bioscience). Growth curves were generated as described previously 13 . Three independent MEF lines for each genotype were analysed in both experiments.
SA-β-galactosidase staining. Adherent MEFs were stained with a SA-β-galactosidase activity kit according to manufacturer's protocol (Cell Signaling). Nuclei were stained with Hoechst to determine percentages of cells positive for SA-β-galactosidase activity. The percentage of SA-β-galactosidase-positive cells was the total number of cells positive for SA-β-galactosidase activity divided by the total number of cells (n = 3 independent MEF lines for each genotype at each passage). Adipose tissue depositions were stained for SA-β-galactosidase activity, as described previously 13 .
Western blot analyses. Western blot analyses were carried out as described previously 48 . Antibodies for senescence-associated proteins were as described 13, 16 . 
